lomustine has been researched along with Carcinoma, Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gervais, R | 1 |
| Le Caer, H | 1 |
| Monnet, I | 1 |
| Falchero, L | 1 |
| Baize, N | 1 |
| Olivero, G | 1 |
| Thomas, P | 1 |
| Berard, H | 1 |
| Auliac, JB | 1 |
| Chouaid, C | 2 |
| Lebeau, B | 1 |
| Baud, M | 1 |
| Masanès, MJ | 1 |
| Febvre, M | 1 |
2 trials available for lomustine and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Second-line oral chemotherapy (lomustine, cyclophosphamide, etoposide) versus intravenous therapy (cyclophosphamide, doxorubicin, and vincristine) in patients with relapsed small cell lung cancer: a randomized phase II study of GFPC 0501.
Topics: Administration, Intravenous; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protoc | 2015 |
Oral second- and third-line lomustine-etoposide-cyclophosphamide chemotherapy for small cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2010 |